These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21697250)

  • 1. Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis.
    Kimball S; Vieth R; Dosch HM; Bar-Or A; Cheung R; Gagne D; O'Connor P; D'Souza C; Ursell M; Burton JM
    J Clin Endocrinol Metab; 2011 Sep; 96(9):2826-34. PubMed ID: 21697250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis.
    Burton JM; Kimball S; Vieth R; Bar-Or A; Dosch HM; Cheung R; Gagne D; D'Souza C; Ursell M; O'Connor P
    Neurology; 2010 Jun; 74(23):1852-9. PubMed ID: 20427749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal vitamin D supplementation during pregnancy prevents vitamin D deficiency in the newborn: an open-label randomized controlled trial.
    Rodda CP; Benson JE; Vincent AJ; Whitehead CL; Polykov A; Vollenhoven B
    Clin Endocrinol (Oxf); 2015 Sep; 83(3):363-8. PubMed ID: 25727810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 16-weeks vitamin D replacement on calcium-phosphate homeostasis in overweight and obese adults.
    Mesinovic J; Mousa A; Wilson K; Scragg R; Plebanski M; de Courten M; Scott D; Naderpoor N; de Courten B
    J Steroid Biochem Mol Biol; 2019 Feb; 186():169-175. PubMed ID: 30367939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-related effects of vitamin D on immune responses in patients with clinically isolated syndrome and healthy control participants: study protocol for an exploratory randomized double- blind placebo-controlled trial.
    O'Connell K; Kelly S; Kinsella K; Jordan S; Kenny O; Murphy D; Heffernan E; O'Laoide R; O'Shea D; McKenna C; Cassidy L; Fletcher J; Walsh C; Brady J; McGuigan C; Tubridy N; Hutchinson M
    Trials; 2013 Aug; 14():272. PubMed ID: 23981773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D supplementation in nursing home patients: randomized controlled trial of standard daily dose versus individualized loading dose regimen.
    Wijnen H; Salemink D; Roovers L; Taekema D; de Boer H
    Drugs Aging; 2015 May; 32(5):371-8. PubMed ID: 25899914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis.
    Soilu-Hänninen M; Aivo J; Lindström BM; Elovaara I; Sumelahti ML; Färkkilä M; Tienari P; Atula S; Sarasoja T; Herrala L; Keskinarkaus I; Kruger J; Kallio T; Rocca MA; Filippi M
    J Neurol Neurosurg Psychiatry; 2012 May; 83(5):565-71. PubMed ID: 22362918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis.
    Hiremath GS; Cettomai D; Baynes M; Ratchford JN; Newsome S; Harrison D; Kerr D; Greenberg BM; Calabresi PA
    Mult Scler; 2009 Jun; 15(6):735-40. PubMed ID: 19383644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different dosages of oral vitamin D supplementation on vitamin D status in healthy, breastfed infants: a randomized trial.
    Gallo S; Comeau K; Vanstone C; Agellon S; Sharma A; Jones G; L'Abbé M; Khamessan A; Rodd C; Weiler H
    JAMA; 2013 May; 309(17):1785-92. PubMed ID: 23632722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of vitamin D on calcium absorption in older women.
    Gallagher JC; Yalamanchili V; Smith LM
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3550-6. PubMed ID: 22855333
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in serum 25-hydroxy-vitamin D response to cholecalciferol in elderly women with secondary hyperparathyroidism and vitamin D deficiency.
    Giusti A; Barone A; Pioli G; Girasole G; Razzano M; Pizzonia M; Pedrazzoni M; Palummeri E; Bianchi G
    J Am Geriatr Soc; 2010 Aug; 58(8):1489-95. PubMed ID: 20646099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of oral continuous low-dose versus short-term high-dose vitamin D: a prospective randomised trial conducted in a clinical setting.
    Hackman KL; Gagnon C; Briscoe RK; Lam S; Anpalahan M; Ebeling PR
    Med J Aust; 2010 Jun; 192(12):686-9. PubMed ID: 20565345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two vitamin D supplementation strategies in children with sickle cell disease: a randomized controlled trial.
    Grégoire-Pelchat P; Pastore Y; Robitaille N; LeMay S; Khamessan A; Kleiber N; Nyalendo C; Gagné N; Alos N; Mailhot G
    Br J Haematol; 2021 Jan; 192(2):385-394. PubMed ID: 33169863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of monthly 50,000 IU or 100,000 IU vitamin D supplements on vitamin D status in premenopausal Middle Eastern women living in Auckland.
    Mazahery H; Stonehouse W; von Hurst PR
    Eur J Clin Nutr; 2015 Mar; 69(3):367-72. PubMed ID: 25491499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fortified malted milk drinks containing low-dose ergocalciferol and cholecalciferol do not differ in their capacity to raise serum 25-hydroxyvitamin D concentrations in healthy men and women not exposed to UV-B.
    Fisk CM; Theobald HE; Sanders TA
    J Nutr; 2012 Jul; 142(7):1286-90. PubMed ID: 22623396
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of oral cholecalciferol 2,000 versus 5,000 IU on serum vitamin D, PTH, bone and muscle strength in patients with vitamin D deficiency.
    Diamond T; Wong YK; Golombick T
    Osteoporos Int; 2013 Mar; 24(3):1101-5. PubMed ID: 22422304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Supplemental vitamin D increases serum cytokines in those with initially low 25-hydroxyvitamin D: a randomized, double blind, placebo-controlled study.
    Barker T; Rogers VE; Levy M; Templeton J; Goldfine H; Schneider ED; Dixon BM; Henriksen VT; Weaver LK
    Cytokine; 2015 Feb; 71(2):132-8. PubMed ID: 25461390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How well are the optimal serum 25OHD concentrations reached in high-dose intermittent vitamin D therapy? a placebo-controlled study on comparison between 100 000 IU and 200 000 IU of oral D3 every 3 months in elderly women.
    Välimäki VV; Löyttyniemi E; Pekkarinen T; Välimäki MJ
    Clin Endocrinol (Oxf); 2016 Jun; 84(6):837-44. PubMed ID: 26725707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of ergocalciferol or cholecalciferol dosing, 1,600 IU daily or 50,000 IU monthly in older adults.
    Binkley N; Gemar D; Engelke J; Gangnon R; Ramamurthy R; Krueger D; Drezner MK
    J Clin Endocrinol Metab; 2011 Apr; 96(4):981-8. PubMed ID: 21289249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D during pregnancy and infancy and infant serum 25-hydroxyvitamin D concentration.
    Grant CC; Stewart AW; Scragg R; Milne T; Rowden J; Ekeroma A; Wall C; Mitchell EA; Crengle S; Trenholme A; Crane J; Camargo CA
    Pediatrics; 2014 Jan; 133(1):e143-53. PubMed ID: 24344104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.